SCHEMBL9727824

SCHEMBL9727824

Cc1cc(CC(N)[C]=O)cc(C)c1C

nearest known ligand 0.33

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ SLC7A5 Q01650 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2264676 1.00 SLC7A5 (0.31) SLC7A5
SCHEMBL2265898 1.00 SLC7A5 (0.31) SLC7A5
SCHEMBL1323343 0.76 THRA (0.38) SLC7A5
SCHEMBL5479611 0.74 SLC6A2 (0.48) —
SCHEMBL17559228 0.73 IDO1 (0.39) —
SCHEMBL1972355 0.73 FFAR1 (0.41) —
SCHEMBL17559229 0.73 IDO1 (0.39) —
SCHEMBL1972357 0.73 FFAR1 (0.41) —
SCHEMBL2266842 0.73 FFAR1 (0.41) —
SCHEMBL6041028 0.73 SIRT5 (0.50) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0417454-A2 Reduced size LHRH analogs ABBOTT LABORATORIES (US) 1991-03-20 — — EP claimed
US-5140009-A Stable against proteolytic enzymes; anticarcinogenic agents; urogenital disorders TAP PHARMACEUTICALS, INC. (US) 1992-08-18 — — US disclosed
EP-0417454-A2 Reduced size LHRH analogs ABBOTT LABORATORIES (US) 1991-03-20 — — EP disclosed
Send feedback